1 year return (CAGR)
184.61%
Bioatla Inc Exchange (NASDAQ, USD)
BCAB
1.77
-0.15 (-7.81%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-5.24%
5 year return (CAGR)
-45.61%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
2.95M
Price/Sales
0.35
Ent value
47.15M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
64.13%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.74 |
| Daily high | 1.77 |
| Daily low | 1.44 |
| Daily Volume | 13K |
| All-time high | 70.91 |
| 1y analyst estimate | 10.00 |
| Beta | 0.76 |
| EPS (TTM) | -18.93 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Mar 2026 |
Downside potential
Loading...
Downside potential data
| BCAB | S&P500 | |
| Current price drop from All-time high | -97.50% | -0.58% |
| Highest price drop | -99.82% | -56.47% |
| Date of highest drop | 2 Apr 2026 | 9 Mar 2009 |
| Avg drop from high | -85.10% | -10.68% |
| Avg time to new high | 58 days | 12 days |
| Max time to new high | 1385 days | 1805 days |
News
